HPV in Adolescents

The HIV Netherlands Australia Thailand Research Collaboration

Status

Completed

Conditions

HPV Infection

Cervical/Anal Dysplasia

Study type

Observational

Funder types

Other

Identifiers

NCT01788852

HIV-NAT 139

Details and patient eligibility

About

This study will assess the prevalence of HPV infection in perinatally HIV-infected adolescents, intraepithelial neoplasia, and E6E7 biomarker at cervical and anal sites.

Full description

Human Papillomavirus (HPV) is the most common sexually transmitted disease and it causes cervical and anal cancer. Prevalence and incidence of HPV infection among young adults who are sexually experienced is high. No data exist for HIV-positive adolescents in regards to HPV infection, cervical and anal intraepithelial neoplasia. This study will compare the prevalence of HPV infection, intraepithelial neoplasia and E6/E7 biomarker at cervical and anal sites among perinatally HIV-infected adolescents, behaviorally HIV-infected adolescents, and HIV-negative adolescents.

Enrollment

27 patients

Sex

All

Ages

12 to 24 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Perinatally-infected (documented positive HIV enzyme immunoassay (EIA) or nucleic acid testing (NAT) at any time and history of maternal HIV infection)
behaviorally-infected (documented positive HIV enzyme immunoassay (EIA) or nucleic acid testing (NAT) at any time after sexual debut without history of maternal HIV infection)
female with vaginal or receptive anal intercourse with a male OR male with receptive rectal intercourse with another male
Signed informed consent. Volunteers aged 12-17 years can decide whether they wish for their parents to consent for their participation. Due to the confidential nature of the issues being studied, parental consent may be exempted

Exclusion criteria